Amgen Narrows FY2026 GAAP EPS Guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 Est

Benzinga Newsdesk www.benzinga.com Positive 81.0%

Neg 0% Neu 0% Pos 81%

Amgen (NASDAQ:AMGN) narrows FY2026 GAAP EPS guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 analyst estimate..

Comments

No comments yet. Be the first!